Purpose: Mutations in destrin (Dstn) cause corneal abnormalities in mice. A null mutation, Dstn corn1 , results in corneal epithelial hyperproliferation, inflammation, and neovascularization in the A.BY background (A.BY Dstn corn1 ). Homozygosity for a point mutation, Dstn corn1-2J , results in mild thickening of the corneal epithelium but no corneal neovascularization in a C57BL/6 (B6) background (B6 Dstn corn1-2J ). The goal of this study was to determine whether phenotypic differences are due to allelic differences between Dstn corn1 and Dstn corn1-2J , or are the result of genetic background effects. Methods: We generated two congenic (Cg) mouse lines, B6.Cg-Dstn corn1 and A.BY.Cg-Dstn corn1-2J , to compare to the original A.BY Dstn corn1 and B6 Dstn corn1-2J lines. We performed immunohistochemistry to assay F-actin accumulation, neovascularization, proliferation, and inflammation. By western blot analysis we tested the expression of serum response factor (SRF), a known regulator of the Dstn corn1 phenotype.
Mutations in the gene for the actin depolymerizing factor destrin (DSTN), lead to abnormalities in the structure and function of the cornea and subsequent blindness in mice [1] [2] [3] . Since actin depolymerizing factors including DSTN function to maintain a homeostatic ratio of actin in two forms, filamentous actin (F-actin) and globular actin (G-actin) [4] , Dstn mutant mice demonstrate the importance of actin dynamics regulation to the proper structure and functions of the cornea. We have previously reported both phenotypic and gene expression differences between two mutations of the Dstn gene, Dstn corn1 and Dstn corn1-2J [2, 3] . The Dstn corn1 mutation is characterized by deletion of a ~35 Kb region containing the entire coding sequence for Dstn, while the Dstn corn1-2J allele has been identified as a point mutation in exon 3, resulting in a Proline to Serine amino acid change in the actin binding domain [3] . Dstn corn1 was isolated and has been maintained in the A.BY genetic background, while has been propagated in the C57BL/6 (B6) background.
There are four major classes of phenotypes that distinguish the two Dstn mutations. First, while both mutants display abnormal levels of F-actin accumulation in the corneal epithelium, consistent with the role of DSTN to depolymerize F-actin, A.BY Dstn corn1 mice display extreme misregulation of actin dynamics, leading to structural breakdown of the corneal epithelium. B6 Dstn corn1-2J mice display mild F-actin accumulation but maintain overall structural integrity of the corneal epithelium [3] . Second, while A.BY Dstn corn1 mice develop neovascularization into the cornea, B6 Dstn corn1-2J cornea remain free of any abnormal vasculature. Third, the A.BY Dstn corn1 mutants demonstrate increased epithelial thickening due to proliferating cells throughout the corneal epithelium when compared to B6 Dstn corn1-2J [1, 3] . Fourth, A.BY Dstn corn1 mutants displayed significant recruitment of inflammatory cells to the corneal epithelium when compared to B6 Dstn corn1-2J [5] . Since these mutations are on different genetic backgrounds, it was impossible to deduce whether phenotypic differences between Dstn corn1 and Dstn
corn1-2J
were solely due to differences in mutant alleles, or if the mutants are differentially affected because of genetic backgrounds. , we can observe the effects of genetic background on the disease phenotypes attributed to different types of mutations. These analyses demonstrated that both allelic difference and genetic background affect the severity of corneal abnormalities caused by the Dstn mutation. , primers mADF-F35 (5′TGG AGG GTG TGC TTT CTC TAC-3′) and mADF-R32 (5′-CTA CGA AGA TAA TAA GGT GGG C-3′) were used for amplification, followed by digestion of the PCR product with the restriction enzyme BanI. Immunohistochemistry: All mice were analyzed at postnatal day 58 (P58), unless otherwise indicated.
METHODS
Immunohistochemistry on frozen sections was performed as described previously [2] . Briefly, after removal, eyes were fixed in paraformaldehyde and gradients of sucrose before sectioning. Immunohistochemistry on whole cornea was performed as described previously [2] . Briefly, after removal of the eye, corneas were removed and fixed in paraformaldehyde overnight. Corneas were then rinsed in PBS and post-fixed in 100% acetone, followed by additional PBS rinses. Corneas were blocked overnight in PBS with 0.8% Triton and 2% normal donkey serum, followed with an overnight incubation with the primary antibody in block solution. The primary antibody for cluster of differentiation 31 (CD31; BD Pharmigen) was used at a dilution of 1:50. Corneas were transferred to block solution containing phalloidin (1:50; Invitrogen) and an Alexa Fluor 488 conjugated secondary antibody (1:200; Invitrogen). Corneas were counterstained with DAPI (1:200; Sigma-Aldrich).
Imaging: Images acquired on sections and whole mount cornea were captured on an Eclipse E600 microscope (Nikon, Tokyo, Japan) using a SPOT camera (Spot Diagnostics, Sterling Heights, MI) or a Zeiss 510 confocal laser scanning system and Axio Imager microscope using LSM 510 software (release 4.2; Carl Zeiss MicroImaging, Thornwood, NY). For images obtained of the surface of eye, mice were sacrificed and immediately placed under the objective of a Zeiss Stemi SV11 dissecting scope attached to a Nikon COOLPIX 995 digital camera (Nikon).
Western blotting: For each line, six corneas pooled from three mice were homogenized in RIPA buffer (1× PBS with 1% NP-40 and 0.1%SDS) containing a protease inhibitor cocktail. Protein concentrations were determined using the Precision Red protein assay reagent (Cytoskeleton, Denver, CO) according to the manufacturer's instructions. Equal amount of protein were subjected to SDS-PAGE using 4%-12% Bis-tris gels and antibodies against SRF (1:1,000; Santa Cruz Biotenchnology, Santa Cruz, CA), and FMR1 (1:4,000; Millipore, Billerica, MA). Blots were treated with horseradish peroxidase conjugated secondary antibodies (1:2,000; Jackson Immunoresearch, West Grove, PA) before detection using a chemiluminescent reagent (Amersham ECL Plus western blotting detection system; General Electric, Buckinghamshire, UK). Blots were then exposed to X-ray film (Thermo Scientific, Rockford, IL). Western blot analyses were performed in both biologic and technical triplicate. FMR1 (fragile X mental retardation syndrome 1 homolog) was used as a loading control, as previously described [6] . 
Histological quantification of proliferating cells and inflammatory cells:
Corneal frozen sections were stained for the proliferation marker Ki67, the pan-leukocyte marker CD45, the neutrophil marker myeloperoxidase (MP), and the nuclear marker DAPI. Cells were counted using ImageJ software on digital images taken using the SPOT Image Analysis system. Two separate, nonconsecutive sections were analyzed for each eye for each phenotype. Quantification of the vascularized area of the cornea: Digital images of all corneal flat mounts were collected using the Spot Image Analysis system. Vascularized area and total corneal area were measured using ImageJ software with a method similar to that of Bock et al. [7] . Briefly, filters were applied to subtract background, reduce noise, and enhance contrast. The total corneal area was outlined using the innermost vessel of the limbal arcade as the border, and the area of CD31-positive vessels within the cornea was then calculated and normalized to the total corneal area (expressed as the percentage of vascularized cornea) using thresh holding analysis. Filters were applied to subtract background, reduce noise, and enhance contrast. The total corneal area was outlined using the innermost vessel of the limbal arcade as the border, and the area of CD31-positive vessels within the cornea was then calculated and normalized to the total corneal area (expressed as the percentage of vascularized cornea) using threshholding analysis. Statistical analysis: For comparison of three groups, a oneway ANOVA was performed, followed by pairwise t-tests with a Bonferroni correction if the ANOVA resulted in a p<0.05. For comparison of two groups, a two-tailed, unpaired t-test was used. GraphPad Prism software (GraphPad, San Diego, CA) was used for statistical analysis and to create all graphs reporting numerical values. *p<0.05, **p<0.01, ***p<0.001.
RESULTS
Characterization of genetic mutations in the gene for DSTN and phenotypic differences in the cornea of A.BY Dstn corn1 and B6 Dstn corn1-2J had been reported previously [1, 3, 5] . mice are characterized by a non-synonymous mutation in the actin binding domain of DSTN that most likely results in hypomorphic activity.
Even upon gross visual analysis, these two Dstn mutations exhibit phenotypic differences at P58 (Figure 1 mice. While this difference is apparent and significant by P28, the difference increases in significance with age ( Figure 3C ).
To detect proliferating cells in the corneal epithelium, we performed immunohistochemistry using an anti-Ki67 antibody. We compared the amount of proliferation in each of the four lines and found that the number of proliferating cells in the corneal epithelia of Dstn corn1 mice is significantly more than that in the corneal epithelia of Dstn is present by P28 and becomes significant by P58 ( Figure 4C ). In contrast, when comparing these phenotypes between A.BY.Cg-Dstn
corn1-2J
and B6 Dstn corn1-2J mice, we did not observe any significant difference.
To detect inflammatory cells in the corneal epithelium, we performed immunohistochemistry using anti-CD45 and anti-myeloperoxidase antibodies. We compared the amount of inflammation in the cornea of mice from each of the four lines. We found that there is significantly increased recruitment of inflammatory cells to the cornea of Dstn corn1 mice when compared to Dstn corn1-2J or WT mice, an observation common to both backgrounds. There is also a significant increase in inflammatory cells in Dstn corn1-2J mutant corneas compared to WT ( Figure 5A,B) . The level of inflammation was significantly increased in the cornea of A.BY Dstn corn1 mice compared to B6.Cg-Dstn corn1 mice ( Figure 5C ). In the corneal epithelium of Dstn corn1 mice, the trend of increased inflammation in the A.BY compared to the B6 background is seen at P28 and becomes significant by P58 ( Figure 5C ). In contrast, when comparing these phenotypes between A.BY.Cg-Dstn
We had previously identified the transcription factor serum response factor (SRF) as a major contributor to Dstn corn1 phenotypes [2, 6] . To assess the quantity of SRF in the Dstn corn1 mutants in both genetic backgrounds, we performed western blot analysis. We found that the level of SRF is higher in Dstn corn1 when compared WT in both backgrounds ( Figure 6A) . Additionally, statistical analysis reveals that the level of induction of SRF expression in Dstn corn1 mutants, that is, the increase relative to WT, is not significantly different between genetic backgrounds. ( Figure  6B ).
Our results suggest that phenotypic differences between Dstn mutants are due to allelic differences. Actin accumulation, neovascularization, proliferation and inflammatory response differences between Dstn corn1 and Dstn
remain consistent when compared in two genetic backgrounds. Notably, phenotypes caused by the Dstn corn1 mutation are also modified by genetic background. In every case, the abnormal phenotype is dampened in the cornea Quantification of the vascularized area shows that Dstn corn1 cornea have significantly more vasculature compared to Dstn corn1-2J and WT cornea in both genetic backgrounds (p<0.001 for both backgrounds). Note that the resting level of vasculature is higher in B6 than A.BY. C: Genetic background effect on the neovascularization phenotype in the Dstn corn1 cornea is significant at postnatal day 28, and becomes even more significant with age. Sample sizes: A.BY.Cg-Dstn corn1-2J P58 n=5, A.BY Dstn corn1 P58 n=11, A.BY WT P58 n=3, B6 Dstn corn1-2J P58 n=4, B6.Cg-Dstn corn1 P58 n=10, B6 WT P58 n=4, A.BY Dstn corn1 P28 n=11, B6.CgDstn corn1 P28 n=6. Error bars, SEM * denotes statistical significance resulting from t-tests, with omitted bars representing nonsignficance. *p<0.05, **p<0.01, ***p<0.001.
Dstn corn1
( Figure 7A,B) . These results suggest the presence of a genetic factor that is variable between B6 and A.BY and affects the phenotype in a dosage-dependent manner.
DISCUSSION

Dstn corn1
and Dstn corn1-2J contribute to observed phenotypic differences: By observing corneal phenotypes on the same genetic background, this study shows that the differences in Figure 4 . Epithelial hyperproliferation in Dstn corn1 corneas. A: Immunofluorescence for Ki67 (green) labels proliferating cells in the corneal epithelium of Dstn mutants and WT mice on A.BY and B6 backgrounds at P58. All slides were counterstained with DAPI to mark cell nuclei (blue), which is shown merged with Ki67 staining in the lower panels. Bar, 20 μm. B: Quantification of Ki67 positive cells shows significantly increased numbers of proliferating cells in Dstn corn1 cornea compared to Dstn corn1-2J and WT cornea in both A.BY and B6 backgrounds at P58 (p<0.001 for both backgrounds). C: A tendency for increased hyperproliferation in A.BY Dstn corn1 compared to B6.Cg-Dstn corn1 is observed by P28. This difference becomes statistically significant by P58. Sample sizes: A.BY.Cg-Dstn corn1-2J P58 n=4, A.BY Dstn corn1 P58 n=5, A.BY WT P58 n=4, B6 Dstn corn1-2J P58 n=3, B6.Cg-Dstn corn1 P58 n=5, B6 WT P58 n=4, A.BY Dstn corn1 P28 n=6, B6.Cg-Dstn corn1 P28 n=3. Unit length=300 μm. Error bars, SEM * denotes statistical significance resulting from t-tests, with omitted bars representing non-significance. *p<0.05, **p<0.01, ***p<0.001.
abnormal phenotypes that we observe in Dstn mutant mice are due to the allelic difference between Dstn is a point mutation [3] . Since the point mutation in to their WT counterparts revealed that the Dstn corn1 mutation led to differential expression of 1,226 annotated genes, whereas the Dstn corn1-2J mutation led to changes in only 202 annotated genes [2] . Based on these observations, we speculate that the modifier or modifiers may belong to or interact with the set of ~1000 genes whose differential expression is observed in Dstn   corn1 and not in Dstn corn1-2J . Another possible reason which could explain genetic modification specific to the Dstn corn1 mutation is the involvement of a compensating mechanism that may be activated by a complete loss of destrin (Dstn ). There are 2 other members of the Figure 5 . Recruitment of inflammatory cells to the cornea of Dstn mutants. A: Immunofluorescence using CD45 (red) to mark inflammatory cells and myeloperoxidase to mark neutrophils specifically in Dstn mutant and WT cornea on A.BY and B6 backgrounds at P58. All slides were counterstained with DAPI to mark cell nuclei (blue). Bar, 20 μm. B: Quantification of CD45 positive cells revealed significantly increased inflammation in both Dstn corn1 and Dstn corn1-2J mutant cornea compared to WT at P58 (p<0.001 for both backgrounds). C: The trend for increased inflammation in A.BY Dstn corn1 compared to B6.Cg-Dstn corn1 is present by P28 and increases to significance by P58. Sample sizes: A.BY.Cg-Dstn corn1-2J P58 n=4, A.BY Dstn corn1 P58 n=8, A.BY WT P58 n=4, B6 Dstn corn1-2J P58 n=4, B6.Cg-Dstn corn1 P58 n=6, B6 WT P58 n=4, A.BY Dstn corn1 P28 n=6, B6.Cg-Dstn corn1 P28 n=3. Unit length=300 um. Error bars, SEM * denotes statistical significance resulting from t-tests, with omitted bars representing non-significance. *p<0.05, **p<0.01, ***p<0.001.
actin depolymerizing factor family in mice, cofilin 1 which is ubiquitously expressed and cofilin 2 which is muscle specific [8] . We previously observed upregulation of cofilins in the A.BY Dstn corn1 cornea, indicating the existence of the compensating mechanism by cofilins [3] . It is possible that compensation by cofilins is more effective in the B6 background compared to the A.BY background, leading to milder phenotypes in the B6.Cg-Dstn Effects of genetic variation on the mouse cornea: Genetic background effects have been observed for various phenotypes in the mouse cornea. The rate of wound healing, along with epithelial migration, was found to be greater in the cornea of B6 mice compared to BALB/c mice [9] . Induced corneal neovascularization [10, 11] as well as lymphangiogenesis [12, 13] has also been shown to be greatly affected by the genetic background. Central corneal thickness, which is known to be associated with the risk for glaucoma, differs among inbred strains of mice [14] and quantitative trait locus (QTL) analysis identified a genetic locus that is significantly associated with this phenotype [15] . Our data demonstrates that genetic background has a significant effect on the severity of Dstn corn1 phenotypes, indicating the presence of a QTL that interacts with this mutation. We subsequently found that the F1 neovascularization phenotype is intermediate to both Dstn corn1 mutants, suggesting that the locus or loci may act in a semi-dominant manner. Future identification of genetic factors responsible for these phenotypic differences in the cornea of Dstn corn1 mice should provide valuable information regarding the molecular networks that regulate homeostasis and pathogenesis in the cornea.
The genetic modifier of Dstn corn1
acts in a pathway independent of SRF: Notably, all known phenotypes caused by the Dstn corn1 mutation are similarly affected by genetic background. This observation suggests that genetic factors responsible for these phenotypic differences act on the part of a molecular pathway that affects all of these phenotypes. We previously identified one transcription factor that appears to be responsible for all phenotypes caused by the Dstn corn1 mutation. Gene expression analysis revealed that multiple molecules that are downstream of the transcription factor SRF, as well as SRF itself, are abnormally upregulated in the cornea of Dstn corn1 mice [2] . Inactivation of SRF specifically in the corneal epithelium of the Dstn corn1 mice rescued all phenotypes caused by this mutation [6] . Data from this study suggest that the level of induction of SRF in Dstn mice affect all phenotypes in a similar manner, we hypothesize that these genetic factors may act downstream from SRF in a molecular pathway, or else function in an independent manner. Further investigation of the SRF pathway along with identification of these genetic factors will test this possibility.
Conclusions:
This study has shown that phenotypic differences between the Dstn mutants Dstn corn1 and Dstn corn1-
2J
are due to allelic differences. Additionally, further analysis revealed that phenotypes caused by the Dstn corn1 mutation are Figure 6 . Western blot analysis for SRF in Dstn corn1 mutant and WT cornea. A: SRF level is greater in Dstn corn1 mutant cornea compared to WT. B: When comparing the induction of SRF expression by the Dstn corn1 mutation (SRF increase in Dstn corn1 with respect to WT) in both the A.BY and B6 background, there is no significant difference in the increase of SRF between these genetic backgrounds. Error bars, SEM * denotes statistical significance resulting from t-tests. *p<0.05, **p<0.01, ***p<0.001, ns=nonsignificant.
modified by genetic background. Our work indicates that there are additional factors that regulate the Dstn corn1 phenotypes other than SRF, which was previously determined as a major contributor. Further identification of factors that play a role in the formation of Dstn corn1 phenotypes will provide valuable insights into the regulation of actin dynamics, absence of vasculature, controlled epithelial proliferation and inflammatory response in the cornea.
